Market Tracker

10/21 2:23pm ET
10.22
Real-Time Quote
 +0.02 / +0.20%
Today’s Change
6.05
Today|||52-Week Range
11.01
+35.63%
Year-to-Date
No recent news for Dyax Corp.

Today’s Trading

Previous close10.20
Today’s open10.33
Day’s range10.07 - 10.37
Volume392,479
Average volume (3 months)966,364
Market cap$1.4B
Dividend yield--
Data as of 2:08pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+28.02%
Earnings growth (next 5 years)+18.64%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book47.16

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.38+2.45%
NKTRNektar Therapeutics-0.11-0.86%
ARIAARIAD Pharmaceutical...-0.04-0.60%
ABCOAdvisory Board Co+0.12+0.24%
Data as of 2:23pm ET, 10/21/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts